1. Home
  2. INSP vs VCEL Comparison

INSP vs VCEL Comparison

Compare INSP & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inspire Medical Systems Inc.

INSP

Inspire Medical Systems Inc.

N/A

Current Price

$70.41

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Logo Vericel Corporation

VCEL

Vericel Corporation

N/A

Current Price

$39.61

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INSP
VCEL
Founded
2007
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.4B
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
INSP
VCEL
Price
$70.41
$39.61
Analyst Decision
Hold
Strong Buy
Analyst Count
17
8
Target Price
★ $62.80
$60.57
AVG Volume (30 Days)
★ 696.7K
397.9K
Earning Date
11-02-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 179.43
60.00
EPS
N/A
★ N/A
Revenue
$82,050,000.00
★ $276,259,000.00
Revenue This Year
N/A
$21.71
Revenue Next Year
$3.95
$16.86
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 62.18
16.45
52 Week Low
$38.91
$28.95
52 Week High
$147.03
$49.32

Technical Indicators

Market Signals
Indicator
INSP
VCEL
Relative Strength Index (RSI) 56.37 47.72
Support Level $55.37 $37.78
Resistance Level $78.80 $41.12
Average True Range (ATR) 3.41 1.17
MACD -0.66 0.26
Stochastic Oscillator 28.77 69.65

Price Performance

Historical Comparison
INSP
VCEL

About INSP Inspire Medical Systems Inc.

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: